MYC Induced Nuclear Antigen (MINA) Peptid
MINA
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle MINA Produkte
- MINA (MYC Induced Nuclear Antigen (MINA))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalog #: ARP39722_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MINA (MYC Induced Nuclear Antigen (MINA))
- Hintergrund
-
MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer
Alias Symbols: MDIG, NO52, MINA53
Protein Interaction Partner: MINA,MYC,MINA
Protein Size: 464 - Molekulargewicht
- 53 kDa
- Gen-ID
- 84864
- NCBI Accession
- NM_032778, NP_116167
- UniProt
- Q96KB0
-
Sie sind hier:
